<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.0 20120330//EN" "JATS-journalpublishing1.dtd">
<article article-type="case-report" dtd-version="1.0" xml:lang="en" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">JRD</journal-id>
<journal-title-group>
<journal-title>Journal of Rheumatic Diseases</journal-title>
<abbrev-journal-title>J Rheum Dis</abbrev-journal-title>
</journal-title-group>
<issn pub-type="ppub">2093-940X</issn>
<issn pub-type="epub">2233-4718</issn>
<publisher>
<publisher-name>The Korean College of Rheumatology</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.4078/jrd.2013.20.1.64</article-id>
<article-id pub-id-type="publisher-id">jrd-20-64</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Case Report</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>A Case of Systemic Lupus Erythematosus with Myelitis and Recurrent Neuromyelitis Optica</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name name-style="western" xml:lang="en">
<surname>Lee</surname><given-names>Ja Young</given-names></name>
<xref ref-type="aff" rid="aff1-jrd-20-64"/>
</contrib>
<contrib contrib-type="author">
<name name-style="western" xml:lang="en">
<surname>Kim</surname><given-names>You Jeong</given-names></name>
<xref ref-type="aff" rid="aff1-jrd-20-64"/>
</contrib>
<contrib contrib-type="author">
<name name-style="western" xml:lang="en">
<surname>Lee</surname><given-names>Ji Hyun</given-names></name>
<xref ref-type="corresp" rid="c1-jrd-20-64"/>
<xref ref-type="aff" rid="aff1-jrd-20-64"/>
</contrib>
<aff id="aff1-jrd-20-64" xml:lang="en">Division of Rheumatology, Department of Internal Medicine, Maryknoll Hospital, Busan, <country>Korea</country></aff>
</contrib-group>
<author-notes>
<corresp id="c1-jrd-20-64">Corresponding to : Ji Hyun Lee, Division of Rheumatology, Department of Internal Medicine, Maryknoll Hospital, Daecheong-dong 4-ga, Jung-gu, Busan 600-730, Korea. E-mail : <email>ete@lycos.co.kr</email></corresp>
</author-notes>
<pub-date pub-type="ppub">
<month>2</month>
<year>2013</year>
</pub-date>
<pub-date pub-type="epub">
<day>31</day>
<month>2</month>
<year>2013</year>
</pub-date>
<volume>20</volume>
<issue>1</issue>
<fpage>64</fpage>
<lpage>67</lpage>
<history>
<date date-type="received"><day>29</day><month>03</month><year>2012</year></date>
<date date-type="revised"><day>17</day><month>04</month><year>2012</year></date>
<date date-type="accepted"><day>17</day><month>04</month><year>2012</year></date>
</history>
<permissions>
<copyright-statement>Copyright &#x00A9; 2013 The Korean College of Rheumatology</copyright-statement>
<copyright-year>2013</copyright-year>
<license><license-p>This is a Free Access article, which permits unrestricted non-commerical use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license>
</permissions>
<abstract xml:lang="en">
<title>Abstract</title>
<p>Neuromyelitis optica (NMO) is an idiopathic, severe inflammatory demyelinating disease of the central nervous system targeting optic nerves and the spinal cord. It is characterized by acute bilateral visual loss (optic neuritis), acute transverse myelitis, and tends to spare brain early in the disease course. NMO can occur as an isolated con-dition or secondary to infection, toxin exposure, and autoimmune disease including systemic lupus erythematosus (SLE), sarcoidosis, and Behcet&#x0027;s disease. We experienced a case of SLE with myelitis and recurrent optic neuritis in a 28-year-old woman who presented with recurrent visual disturbance and sudden onset of paraplegia, and report here on this case along with a review of the relevant literature.</p>
</abstract>
<kwd-group xml:lang="en">
<kwd>Systemic lupus erythematosus</kwd>
<kwd>Neuromyelitis optica</kwd>
</kwd-group>
</article-meta>
</front>
<back>
<ref-list>
<title>References</title>
<ref id="b1-jrd-20-64"><label>1.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wingerchuk</surname> <given-names>DM</given-names></name> <name><surname>Hogancamp</surname> <given-names>WF</given-names></name> <name><surname>O&#x0027;Brien</surname> <given-names>PC</given-names></name> <name><surname>Weinshenker</surname> <given-names>BG</given-names></name></person-group> <article-title>The clinical course of neuromyelitis optica (Devic&#x0027;s syndrome)</article-title> <source>Neurology</source> <year>1999</year> <volume>53</volume> <fpage>1107</fpage><lpage>14</lpage></element-citation></ref>
<ref id="b2-jrd-20-64"><label>2.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mandler</surname> <given-names>RN</given-names></name></person-group> <article-title>Neuromyelitis optica - Devic&#x0027;s syndrome, update</article-title> <source>Autoimmun Rev</source> <year>2006</year> <volume>5</volume> <fpage>537</fpage><lpage>43</lpage></element-citation></ref>
<ref id="b3-jrd-20-64"><label>3.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ahn</surname> <given-names>TB</given-names></name> <name><surname>Yoon</surname> <given-names>BW</given-names></name></person-group> <article-title>A case of systemic lupus erythematosus with recurrent myelitis and optic neuritis</article-title> <source>J Korean Neurol Assoc</source> <year>2000</year> <volume>18</volume> <fpage>657</fpage><lpage>60</lpage></element-citation></ref>
<ref id="b4-jrd-20-64"><label>4.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Oh</surname> <given-names>PC</given-names></name> <name><surname>Kim</surname> <given-names>GH</given-names></name> <name><surname>Jin</surname> <given-names>CH</given-names></name> <name><surname>Baek</surname> <given-names>HJ</given-names></name></person-group> <article-title>A case of systemic lupus erythematous associated with neuromyelitis optica (Devic&#x0027;s Syndrome)</article-title> <source>J Korean Rheum Assoc</source> <year>2007</year> <volume>14</volume> <fpage>263</fpage><lpage>7</lpage></element-citation></ref>
<ref id="b5-jrd-20-64"><label>5.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wingerchuk</surname> <given-names>DM</given-names></name> <name><surname>Lennon</surname> <given-names>VA</given-names></name> <name><surname>Pittock</surname> <given-names>SJ</given-names></name> <name><surname>Lucchinetti</surname> <given-names>CF</given-names></name> <name><surname>Weinshenker</surname> <given-names>BG</given-names></name></person-group> <article-title>Revised diagnostic criteria for neuromyelitis optica</article-title> <source>Neurology</source> <year>2006</year> <volume>66</volume> <fpage>1485</fpage><lpage>9</lpage></element-citation></ref>
<ref id="b6-jrd-20-64"><label>6.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lennon</surname> <given-names>VA</given-names></name> <name><surname>Wingerchuk</surname> <given-names>DM</given-names></name> <name><surname>Kryzer</surname> <given-names>TJ</given-names></name> <name><surname>Pittock</surname> <given-names>SJ</given-names></name> <name><surname>Lucchinetti</surname> <given-names>CF</given-names></name> <name><surname>Fujihara</surname> <given-names>K</given-names></name> <etal/></person-group> <article-title>A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis</article-title> <source>Lancet</source> <year>2004</year> <volume>364</volume> <fpage>2106</fpage><lpage>12</lpage></element-citation></ref>
<ref id="b7-jrd-20-64"><label>7.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Takahashi</surname> <given-names>T</given-names></name> <name><surname>Fujihara</surname> <given-names>K</given-names></name> <name><surname>Nakashima</surname> <given-names>I</given-names></name> <name><surname>Misu</surname> <given-names>T</given-names></name> <name><surname>Miyaza-wa</surname> <given-names>I</given-names></name> <name><surname>Nakamura</surname> <given-names>M</given-names></name> <etal/></person-group> <article-title>Anti-aquaporin-4 antibody is involved in the pathogenesis of NMO: a study on antibody titre</article-title> <source>Brain</source> <year>2007</year> <volume>130</volume> <fpage>1235</fpage><lpage>43</lpage></element-citation></ref>
<ref id="b8-jrd-20-64"><label>8.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jarius</surname> <given-names>S</given-names></name> <name><surname>Aboul-Enein</surname> <given-names>F</given-names></name> <name><surname>Waters</surname> <given-names>P</given-names></name> <name><surname>Kuenz</surname> <given-names>B</given-names></name> <name><surname>Hauser</surname> <given-names>A</given-names></name> <name><surname>Berger</surname> <given-names>T</given-names></name> <etal/></person-group> <article-title>Antibody to aquaporin-4 inthe longterm course of neuromyelitis optica</article-title> <source>Brain</source> <year>2008</year> <volume>131</volume> <fpage>3072</fpage><lpage>80</lpage></element-citation></ref>
<ref id="b9-jrd-20-64"><label>9.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mok</surname> <given-names>CC</given-names></name> <name><surname>Lau</surname> <given-names>CS</given-names></name> <name><surname>Chan</surname> <given-names>EY</given-names></name> <name><surname>Wong</surname> <given-names>RW</given-names></name></person-group> <article-title>Acute transverse myelopathy in systemic lupus erythematosus: clinical presentation, treatment, and outcome</article-title> <source>J Rheumatol</source> <year>1998</year> <volume>25</volume> <fpage>467</fpage><lpage>73</lpage></element-citation></ref>
<ref id="b10-jrd-20-64"><label>10.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sellner</surname> <given-names>J</given-names></name> <name><surname>Boggild</surname> <given-names>M</given-names></name> <name><surname>Clanet</surname> <given-names>M</given-names></name> <name><surname>Hintzen</surname> <given-names>RQ</given-names></name> <name><surname>Illes</surname> <given-names>Z</given-names></name> <name><surname>Montalban</surname> <given-names>X</given-names></name> <etal/></person-group> <article-title>EFNS guidelines on diagnosis and management of neuromyelitis optica</article-title> <source>Eur J Neurol</source> <year>2010</year> <volume>17</volume> <fpage>1019</fpage><lpage>32</lpage></element-citation></ref>
<ref id="b11-jrd-20-64"><label>11.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Weinshenker</surname> <given-names>BG</given-names></name> <name><surname>O&#x0027;Brien</surname> <given-names>PC</given-names></name> <name><surname>Petterson</surname> <given-names>TM</given-names></name> <name><surname>Nosewor-thy</surname> <given-names>JH</given-names></name> <name><surname>Lucchinetti</surname> <given-names>CF</given-names></name> <name><surname>Dodick</surname> <given-names>DW</given-names></name> <etal/></person-group> <article-title>A randomized trial of plasma exchange in acute central nervous system inflammatory demyelinating disease</article-title> <source>Ann Neurol</source> <year>1999</year> <volume>46</volume> <fpage>878</fpage><lpage>86</lpage></element-citation></ref>
<ref id="b12-jrd-20-64"><label>12.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lucchinetti</surname> <given-names>CF</given-names></name> <name><surname>Mandler</surname> <given-names>RN</given-names></name> <name><surname>McGavern</surname> <given-names>D</given-names></name> <name><surname>Bruck</surname> <given-names>W</given-names></name> <name><surname>Gleich</surname> <given-names>G</given-names></name> <name><surname>Ransohoff</surname> <given-names>RM</given-names></name> <etal/></person-group> <article-title>A role for humoral mechanisms in the pathogenesis of Devic&#x0027;s neuromyelitis optica</article-title> <source>Brain</source> <year>2002</year> <volume>125</volume> <fpage>1450</fpage><lpage>61</lpage></element-citation></ref>
<ref id="b13-jrd-20-64"><label>13.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cree</surname> <given-names>BA</given-names></name> <name><surname>Lamb</surname> <given-names>S</given-names></name> <name><surname>Morgan</surname> <given-names>K</given-names></name> <name><surname>Chen</surname> <given-names>A</given-names></name> <name><surname>Waubant</surname> <given-names>E</given-names></name> <name><surname>Genain</surname> <given-names>C</given-names></name></person-group> <article-title>An open label study of the effects of rituximab in neuromyelitis optica</article-title> <source>Neurology</source> <year>2005</year> <volume>64</volume> <fpage>1270</fpage><lpage>2</lpage></element-citation></ref>
<ref id="b14-jrd-20-64"><label>14.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jacob</surname> <given-names>A</given-names></name> <name><surname>Weinshenker</surname> <given-names>BG</given-names></name> <name><surname>Violich</surname> <given-names>I</given-names></name> <name><surname>McLinskey</surname> <given-names>N</given-names></name> <name><surname>Krupp</surname> <given-names>L</given-names></name> <name><surname>Fox</surname> <given-names>RJ</given-names></name> <etal/></person-group> <article-title>Treatment of neuromyelitis optica with rituximab: retrospective analysis of 25 patients</article-title> <source>Arch Neurol</source> <year>2008</year> <volume>65</volume> <fpage>1443</fpage><lpage>8</lpage></element-citation></ref>
</ref-list>
<sec sec-type="display-objects">
<title>Figures</title>
<fig id="F1-jrd-20-64" position="anchor">
<label>Figure 1.</label>
<caption xml:lang="en"><p>A 28-year-old woman diagnosed with systemic lupus erythematosus, presented with recurrent visual disturbance and sudden onset of paraplegia. (A) Sagittal T2-weighted magnetic resonance image of the cervical spine shows cord enlargement and longitudinal hyperintense lesion extending over 7 vertebral seg-ments. (B) Sagittal fat suppression T2-weighted magnetic resonance image of the cervico-thoracic spine shows a diffuse hyperintense lesion through the cervico-thoracic spine cord from C4 to T10 level.</p></caption>
<graphic xlink:href="jrd-20-64f1.tif"/>
</fig>
<fig id="F2-jrd-20-64" position="anchor">
<label>Figure 2.</label>
<caption xml:lang="en"><p>Axial T1-weighted contrast enhanced fat suppression image of brain demonstrates subtle enhancement at the right intraorbital nerve (arrow).</p></caption>
<graphic xlink:href="jrd-20-64f2.tif"/>
</fig>
</sec>
</back>
</article>